1) McKhann GM, Knopman DS, Chertkow H, et al : The diagnosis of dementia due to Alzheimer's disease : Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 : 263-269, 2011.
2) Albert MS, DeKosky ST, Dickson D, et al : The diagnosis of mild cognitive impairment due to Alzheimer's disease : recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 : 270-279, 2011.
3) Sperling RA, Aisen PS, Becket LA, et al : Toward defining the preclinical stages of Alzheimer's disease : recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 : 280-292, 2011.
4) Jack CR Jr., Bennett DA, Blennow K, et al : NIA-AA Research Framework : Toward a biological definition of Alzheimer's disease Alzheimers Dement 14 : 535-562, 2018.
5) Dubois B, Feldman HH, Jacova C, et al : Advancing research diagnostic criteria for Alzheimer's disease : the IWG-2 criteria. Lancet Neurol 13 : 614-629, 2014.
6) Sakae N, Josephs KA, Litvan I, et al : Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome. Alzheimers Dement 15 : 1218-1228, 2019.
7) Han L, Cole M, Bellavance F, et al : Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination : A meta-analysis. Int Psychogeriatr 12 : 231-247, 2000.
8) Schmidt C, Wolff M, Weitz M, et al : Rapidly progressive Alzheimer disease. Arch Neurol 68 : 1124-1130, 2011.
9) Bernick C, Cummings J, Raman R, et al : Age and rate of cognitive decline in Alzheimer disease : Implications for clinical trials. Arch Neurol 69 : 901-905, 2012.
10) Peters ME, Schwartz S, Han D, et al : Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death : The Cache County Dementia Progression Study. Am J Psychiatry 172 : 460-465, 2015.
11) Whitwell JL, Dickson DW, Murray ME et al : Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease : a case-control study Lancet Neurol 11 : 868-877, 2012.
12) Murray ME, Graff-Radford NR, Ross OA, et al : Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics : a retrospective study. Lancet Neurol 10 : 785-796, 2011.
13) Wada-Isoe K, Kikuchi T, Umeda-Kameyama Y, et al : Validation of the Neuropsychiatric Inventory Based on Item Response Theory. J Alzheimers Dis Rep 4 : 151-159, 2020.
14) Petersen RC, Smith GE, Waring SC, et al : Mild cognitive impairment : clinical characterization and outcome. Arch Neurol 56 : 303-308, 1999.
15) 日本精神神経学会 日本語版用語監修, 高橋三郎, 大野裕監訳, DSM-5 精神疾患の診断・統計マニュアル, 東京, 医学書院, 2014.
16) 日本神経学会監, 「認知症疾患治療ガイドライン」作成委員会編 : 認知症疾患治療ガイドライン 2017, 医学書院, 東京, 2017.
17) van Maurik IS, Vos SJ, Bos I et al : Biomarker-based prognosis for people with mild cognitive impairment (ABIDE) : a modelling study Lancet Neurol 18 : 1034-1044, 2019
19) Morris JC, M Storandt, D W McKeel Jr, et al : Cerebral amyloid deposition and diffuse plaques in "normal" aging : Evidence for presymptomatic and very mild Alzheimer's disease. Neurology 46 : 707-719, 1996.
20) Rowe CC, Ellis KA, Rimajova M, et al : Bourgeat PAmyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31 : 1275-1283, 2010.
21) Bateman RJ, Xiong C, Benzinger TL, et al : Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367 : 795-804, 2012.